Especifique uma ação ou criptomoeda na barra de pesquisa para obter um resumo
Laurus Labs Limited
LAURUSLABSLaurus Labs Limited, together with its subsidiaries, manufactures and sells medicines and active pharmaceutical ingredients (APIs) in India and internationally. The company offers Generics APIs for advanced intermediates for anti-retroviral (ARV), antidiabetic, cardiovascular, anti-asthma, ophthalmology, oncology, gastroenterology, and hepatitis C therapeutic areas. It also provides oral solid formulations for ARVs, anti-diabetic, cardiovascular, and PPIs. In addition, the company offers contract development and manufacturing organizational services; and biotechnology services used in the nutraceutical, dietary supplements, alternate food proteins, and cosmeceutical products. Further, the company develops novel enzymatic solutions for industrial biotechnology, and animal origin free recombinant proteins and enzymes for biopharma; and offers business support services for pharmaceuticals field. Laurus Labs Limited was incorporated in 2005 and is based in Hyderabad, India. Address: Serene Chambers, Hyderabad, India, 500034
Analytics
Preço Alvo de Wall Street
47 253.13 INRRácio P/E
203.8163Rendimento de dividendos
0.17 %Ano atual
Ano passado
Trimestre Atual
Ultimo quarto
Ano atual
Ano passado
Trimestre Atual
Ultimo quarto
Figuras chave LAURUSLABS
Análise de Dividendos LAURUSLABS
Crescimento de dividendos em 5 anos
433 %Crescimento contínuo
–Taxa de pagamento em média de 5 anos
37 %Histórico de Dividendos LAURUSLABS
Avaliação de ações LAURUSLABS
Relatório LAURUSLABS
Acompanhe as principais métricas de cada ação em um só lugar, sem complicações
Inscreva-se no premiumResultados | 2019 | Dinâmica |